Cargando…
Commentary: Autoimmune diseases in patients with myotonic dystrophy type 2
Autores principales: | Damen, Manon J., den Broeder, Alfons A., Voermans, Nicol C., Tieleman, Alide A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713809/ https://www.ncbi.nlm.nih.gov/pubmed/36468046 http://dx.doi.org/10.3389/fneur.2022.1041437 |
Ejemplares similares
-
Ancestral Origin of the First Indian Families with Myotonic Dystrophy Type 2
por: Damen, Manon, et al.
Publicado: (2021) -
Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2
por: Peric, Stojan, et al.
Publicado: (2022) -
High disease impact of myotonic dystrophy type 2 on physical and mental functioning
por: Tieleman, Alide A., et al.
Publicado: (2011) -
TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
por: Bosè, Francesca, et al.
Publicado: (2019) -
Myotonic Dystrophy—A Progeroid Disease?
por: Meinke, Peter, et al.
Publicado: (2018)